Basic and Diluted Net Income (Loss) per Share |
Basic and Diluted Net Income (Loss) per Share The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
(In thousands, except share and per share data) |
|
(In thousands, except share and per share data) |
Numerator: |
|
|
|
|
|
|
|
Net income (loss) |
$ |
(23,201) |
|
|
$ |
127,950 |
|
|
$ |
(59,399) |
|
|
$ |
62,608 |
|
Denominator: |
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
193,917,908 |
|
|
184,282,194 |
|
|
191,775,367 |
|
|
183,892,304 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
Common stock options |
— |
|
|
18,043,859 |
|
|
— |
|
|
19,130,274 |
|
Restricted stock units |
— |
|
|
— |
|
|
— |
|
|
3,890 |
|
Diluted weighted average shares outstanding |
193,917,908 |
|
|
202,326,053 |
|
|
191,775,367 |
|
|
203,026,468 |
|
Net income (loss) per share |
|
|
|
|
|
|
|
Basic |
$ |
(0.12) |
|
|
$ |
0.69 |
|
|
$ |
(0.31) |
|
|
$ |
0.34 |
|
Diluted |
$ |
(0.12) |
|
|
$ |
0.63 |
|
|
$ |
(0.31) |
|
|
$ |
0.31 |
|
The following potentially dilutive shares of common stock equivalents “on an as-converted basis” were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
|
|
|
|
|
|
Common stock options |
15,257,468 |
|
|
1,493,147 |
|
|
15,257,468 |
|
|
406,732 |
|
Common stock warrants |
13,145,000 |
|
|
13,075,000 |
|
|
13,145,000 |
|
|
13,075,000 |
|
Restricted stock units |
12,227,171 |
|
|
5,355,860 |
|
|
12,227,171 |
|
|
5,351,970 |
|
Total potentially dilutive common share equivalents |
40,629,639 |
|
|
19,924,007 |
|
|
40,629,639 |
|
|
18,833,702 |
|
Total potentially dilutive common share equivalents for the three and six months ended June 30, 2023 and 2022 excludes 21,265,936 and 21,758,148, respectively, shares related to the earnout liability as these shares are contingently issuable upon meeting certain triggering events.
|